Medicalgorithmics Receives Approval for Commercialization in Canada for the Latest Generation of DeepRhythmAI Artificial Intelligence Algorithms
The new generation of DeepRhythmAI (DRAI) artificial intelligence algorithms, used for analyzing ECG data, has obtained Health Canada registration for use in Canada. This is another regulatory approval—following the U.S. FDA and European CE certification—for the latest generation of AI algorithms developed by Medicalgorithmics. Canada is one of the key markets for the company, where it offers its services in ECG data analysis.